ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.

By R. Pasternak, Sidney C. Smith, C. Bairey-Merz, S. Grundy, J. Cleeman, C. Lenfant. Circulation, 2002

701 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study (2005, positive): “In accordance with guidelines for the use of statin therapy [23], muscular symptoms were managed either by switching the patient to a different lipid-lowering agent (generally another statin), continuing the same statin at a lower dosage, or discontinuing statin therapy completely.”
Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. (2003, background): “Despite the effectiveness and safety of statins, there are still some individuals for whom physicians are reluctant to prescribe statins because of elevations of muscle or liver enzymes.(49) There are also those who would prefer to control their blood lipid levels by nonpharmacological means, partic”